Atopic Dermatitis      

FOI REFERENCE: 24276  FOI DATE: 5^th August 2024       

1. How many patients were treated in the last 4 months (April to July 2024) by the dermatology department with each of the following products:

Abrocitinib	0
Acitretin	0
Alitretinoin	0
Azathioprine	0
Baricitinib	0
Ciclosporin	0
Dupilumab	28
Lebrikizumab	0
Methotrexate	13
Mycophenolate mofetil	0
Pimecrolimus
Phototherapy (UVB or PUVA) – for Atopic Dermatitis only	0
Tacrolimus ointment	0
Tralokinumab	*
Upadacitinib	0

2. Of the patients treated in the last 4 months with any of the products listed in question 1, please provide the number of patients by the following age group:

Age 6-11	0
Age 12-17	0
Age 18 and above	43

*This relates to low numbers between 1 and 5. Under section 40 (ii) of the Freedom of Information Act 2000, statistically low numbers that potentially identify personal data are required to be withheld because of the Trusts obligation to protect personal data under the Data Protection Act 2018